HBK Sorce Advisory »

Capricor Therapeutics shares owned by HBK Sorce Advisory

Quarter-by-quarter ownership of Capricor Therapeutics (CAPR) shares owned by HBK Sorce Advisory from 13F filings

Historical chart of HBK Sorce Advisory investment in Capricor Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Capricor Therapeutics held by HBK Sorce Advisory consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Capricor Therapeutics by HBK Sorce Advisory

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.1M 171k 6.69
2025-06-30 $1.3M 128k 9.93
2025-03-31 $473k 50k 9.49

More positions owned by HBK Sorce Advisory

Schwab Strategic Tr Us Lrg Cap Etf (SCHX)
Vanguard Malvern Fds Core Bd Etf (VCRB)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Dimensional Etf Trust Us Large Cap Vec (DFVX)
Apple (AAPL)
Schwab Strategic Tr Us Brd Mkt Etf (SCHB)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Schwab Strategic Tr Emrg Mkteq Etf (SCHE)
Invesco Exch Trd Slf Idx Rusl 1000 Dynm (OMFL)
Microsoft Corporation (MSFT)
Dimensional Etf Trust Core Fixed Incom (DFCF)
NVIDIA Corporation (NVDA)
Vanguard Mun Bd Fds Tax Exempt Bd (VTEB)
JPMorgan Chase & Co. (JPM)
Vanguard Index Fds Total Stk Mkt (VTI)

View all positions for HBK Sorce Advisory

Top funds holding Capricor Therapeutics

BlackRock
Vanguard Group
Susquehanna International
Citadel Advisors
Geode Capital Management
Caption Management
State Street Corporation
LMR Partners
J. Goldman & Co
Morgan Stanley
Pier Capital
DG Capital Management
Ikarian Capital
Millennium Management
National Bank Of Canada /fi/

View all funds holding Capricor Therapeutics